Updates on US mpox research: surveillance, testing, vaccines and research

Simon Collins, HIV i-Base

Four talks covering the current understanding about mpox and plans for future research are now available online.

These form part of a virtual meeting to be held on 31 March 2023 to discuss the US government’s approaches to mpox.

The studies include selected reports covering vaccine efficacy and also early research by Moderna to develop an mRNA vaccine against mpox. Treatment studies include using tecovirimat both in the US and the Democratic Republic of Congo (DRC) and a programme to look for new drugs.

The talks also provide an update on international studies with multiple partners. This includes studies using tecovirimat to treat mpox, both in the US and the Democratic Republic of Congo (DRC) and other research looking at mpox in Nigeria, Cameroon and DRC countries.

Research also covers genomic surveillance looking at the development of mpox viruses and susceptibility in various animal populations.

Registration for the meeting is at this link.

Reference Mpox Research Gathering. (31 March 2023).

This report was first published on 1 April 2023.

Links to other websites are current at date of posting but not maintained.